HCFA: HHS Secty. Heckler's Chief of Staff C. McClain Haddow assuming added post of Health Care Financing Administration chief until a successor is found. Appointment indicates that permanent successor to Carolyne Davis, PhD, wili not be named for severai months, at least. HHS has had difficulty in clearing appointments with White House. In addition, Washington buzz taik maintains relations between Heckler and White House staff have become strained. Aug. 16 Washington Post article quoted unnamed White House sources that Heckler is under consideration for ambassadorship. In the article, Heckler denied plans to leave HHS. . . .
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.